SABBY 13G SYN 11.17.16

Company

Theriva Biologics, Inc.

Filed

November 17, 2016

Accession Number

0001535610-16-000168

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →